Cargando…
The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
BACKGROUND AND AIM: Methylated SEPT9 is a novel circulating tumor DNA marker for colorectal cancer, while the effects of various colorectal cancer clinicopathological factors on its detection performance have not been fully evaluated. This study aims to investigate the significance of the clinicopat...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144579/ https://www.ncbi.nlm.nih.gov/pubmed/30223720 http://dx.doi.org/10.1177/1533033818791794 |
_version_ | 1783356124527853568 |
---|---|
author | He, Na Song, Lele Kang, Qian Jin, Peng Cai, Guoxiang Zhou, Jinfeng Zhou, Guangpeng Sheng, Jianqiu Cai, Sanjun Wang, Jianming Han, Xiaoliang Nie, Yongzhan Wu, Kaichun |
author_facet | He, Na Song, Lele Kang, Qian Jin, Peng Cai, Guoxiang Zhou, Jinfeng Zhou, Guangpeng Sheng, Jianqiu Cai, Sanjun Wang, Jianming Han, Xiaoliang Nie, Yongzhan Wu, Kaichun |
author_sort | He, Na |
collection | PubMed |
description | BACKGROUND AND AIM: Methylated SEPT9 is a novel circulating tumor DNA marker for colorectal cancer, while the effects of various colorectal cancer clinicopathological factors on its detection performance have not been fully evaluated. This study aims to investigate the significance of the clinicopathological factors on methylated SEPT9 performance in a symptomatic endoscopy cohort, with a specific focus on colorectal cancer. METHODS: A total of 1160 participants were recruited in this study, including 300 patients with colorectal cancer, 122 patients with adenoma, 103 patients with hyperplastic polyps, 568 normal participants (no evidence of disease), and 67 patients with other gastrointestinal diseases. Peripheral blood samples of these participants were collected from 3 Chinese hospitals, and the methylated SEPT9 level was measured using the Epi proColon 2.0 assay. RESULTS: Cancer stage, size, and invasion depth were positively correlated with the detection sensitivity, while no difference in sensitivity was identified among cancers at various locations. Infiltrative colorectal cancer exhibited higher sensitivity than ulcerative and protrude colorectal cancer, while no difference in sensitivity was observed among assessed histological types. The colorectal cancer differentiation showed a clear correlation with the cancer stage, and moderate and poorly differentiated colorectal cancer exhibited higher sensitivity than well-differentiated colorectal cancer. Furthermore, colorectal cancer with distal metastasis (M1) showed higher sensitivity than those without any metastasis, while colorectal cancer with lymph node metastasis (N1 and N2) did not show statistical significance compared to those without it. Finally, local vessel or nerve invasion did not affect the sensitivity. CONCLUSION: Factors that reflect the colorectal cancer intrinsic properties, including cancer stage, size, invasion depth, classification, differentiation, and metastasis, exhibited significant effect on the mSEPT9 detection performance. |
format | Online Article Text |
id | pubmed-6144579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-61445792018-09-21 The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA He, Na Song, Lele Kang, Qian Jin, Peng Cai, Guoxiang Zhou, Jinfeng Zhou, Guangpeng Sheng, Jianqiu Cai, Sanjun Wang, Jianming Han, Xiaoliang Nie, Yongzhan Wu, Kaichun Technol Cancer Res Treat Original Article BACKGROUND AND AIM: Methylated SEPT9 is a novel circulating tumor DNA marker for colorectal cancer, while the effects of various colorectal cancer clinicopathological factors on its detection performance have not been fully evaluated. This study aims to investigate the significance of the clinicopathological factors on methylated SEPT9 performance in a symptomatic endoscopy cohort, with a specific focus on colorectal cancer. METHODS: A total of 1160 participants were recruited in this study, including 300 patients with colorectal cancer, 122 patients with adenoma, 103 patients with hyperplastic polyps, 568 normal participants (no evidence of disease), and 67 patients with other gastrointestinal diseases. Peripheral blood samples of these participants were collected from 3 Chinese hospitals, and the methylated SEPT9 level was measured using the Epi proColon 2.0 assay. RESULTS: Cancer stage, size, and invasion depth were positively correlated with the detection sensitivity, while no difference in sensitivity was identified among cancers at various locations. Infiltrative colorectal cancer exhibited higher sensitivity than ulcerative and protrude colorectal cancer, while no difference in sensitivity was observed among assessed histological types. The colorectal cancer differentiation showed a clear correlation with the cancer stage, and moderate and poorly differentiated colorectal cancer exhibited higher sensitivity than well-differentiated colorectal cancer. Furthermore, colorectal cancer with distal metastasis (M1) showed higher sensitivity than those without any metastasis, while colorectal cancer with lymph node metastasis (N1 and N2) did not show statistical significance compared to those without it. Finally, local vessel or nerve invasion did not affect the sensitivity. CONCLUSION: Factors that reflect the colorectal cancer intrinsic properties, including cancer stage, size, invasion depth, classification, differentiation, and metastasis, exhibited significant effect on the mSEPT9 detection performance. SAGE Publications 2018-09-17 /pmc/articles/PMC6144579/ /pubmed/30223720 http://dx.doi.org/10.1177/1533033818791794 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article He, Na Song, Lele Kang, Qian Jin, Peng Cai, Guoxiang Zhou, Jinfeng Zhou, Guangpeng Sheng, Jianqiu Cai, Sanjun Wang, Jianming Han, Xiaoliang Nie, Yongzhan Wu, Kaichun The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA |
title | The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA |
title_full | The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA |
title_fullStr | The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA |
title_full_unstemmed | The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA |
title_short | The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA |
title_sort | pathological features of colorectal cancer determine the detection performance on blood ctdna |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144579/ https://www.ncbi.nlm.nih.gov/pubmed/30223720 http://dx.doi.org/10.1177/1533033818791794 |
work_keys_str_mv | AT hena thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT songlele thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT kangqian thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT jinpeng thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT caiguoxiang thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT zhoujinfeng thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT zhouguangpeng thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT shengjianqiu thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT caisanjun thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT wangjianming thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT hanxiaoliang thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT nieyongzhan thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT wukaichun thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT hena pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT songlele pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT kangqian pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT jinpeng pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT caiguoxiang pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT zhoujinfeng pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT zhouguangpeng pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT shengjianqiu pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT caisanjun pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT wangjianming pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT hanxiaoliang pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT nieyongzhan pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna AT wukaichun pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna |